MICAFUNGIN FOR INJECTION, USP DIN 02568179
Status: Approved
Holder: BIOCON PHARMA LIMITED
Health Canada record
| Active ingredient(s) | MICAFUNGIN SODIUM 50 MG |
|---|
| Dosage form | Powder For Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | J02AX05 MICAFUNGIN |
|---|
| Original market date | |
|---|
| Current status date | 08-May-2026 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MICAFUNGIN SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02568195 | MICAFUNGIN FOR INJECTION, USP | BIOCON PHARMA LIMITED | Powder For Solution | MICAFUNGIN SODIUM 100 MG | Approved |
| 02532344 | MICAFUNGIN SODIUM FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | MICAFUNGIN SODIUM 50 MG | Marketed |
| 02532360 | MICAFUNGIN SODIUM FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | MICAFUNGIN SODIUM 100 MG | Marketed |
| 02294222 | MYCAMINE | SANDOZ CANADA INCORPORATED | Powder For Solution | MICAFUNGIN SODIUM 50 MG | Cancelled Post Market |
| 02311054 | MYCAMINE | SANDOZ CANADA INCORPORATED | Powder For Solution | MICAFUNGIN SODIUM 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 37518 | 2026-05-08 | Abbreviated New Drug Submission (ANDS) | |
International API supply for MICAFUNGIN SODIUM
12 active FDA Drug Master Files.
Request a quote for MICAFUNGIN FOR INJECTION, USP
How to read a Canadian DIN record